Skip to Main content Skip to Navigation
Journal articles

Electrophoretic drug delivery for seizure control

Abstract : The persistence of intractable neurological disorders necessitates novel therapeutic solutions. We demonstrate the utility of direct in situ electrophoretic drug delivery to treat neurological disorders. We present a neural probe incorporating a microfluidic ion pump (FIP) for on-demand drug delivery and electrodes for recording local neu-ral activity. The FIP works by electrophoretically pumping ions across an ion exchange membrane and thereby delivers only the drug of interest and not the solvent. This "dry" delivery enables precise drug release into the brain region with negligible local pressure increase. The therapeutic potential of the FIP probe is tested in a rodent model of epilepsy. The FIP probe can detect pathological activity and then intervene to stop seizures by delivering inhibitory neurotransmitters directly to the seizure source. We anticipate that further tailored engineering of the FIP platform will enable additional applications in neural interfacing and the treatment of neuro-logical disorders.
Keywords : Neurology Drug Drugs
Complete list of metadatas

Cited literature [53 references]  Display  Hide  Download

https://hal-amu.archives-ouvertes.fr/hal-02269266
Contributor : Christophe Bernard <>
Submitted on : Thursday, August 22, 2019 - 3:42:25 PM
Last modification on : Friday, February 14, 2020 - 10:13:53 AM
Long-term archiving on: : Friday, January 10, 2020 - 3:51:07 PM

File

ProctorSciAdv18.pdf
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

Citation

Christopher Proctor, Andrea Slézia, Attila Kaszás, Antoine Ghestem, Isabel del Agua, et al.. Electrophoretic drug delivery for seizure control. Biochem. (Life Sci. Adv.), 2018, 4 (8), pp.eaau1291. ⟨10.1126/sciadv.aau1291⟩. ⟨hal-02269266⟩

Share

Metrics

Record views

71

Files downloads

134